Linda B Cottler1, Shaun Ajinkya2, Bruce A Goldberger3, Mohammad Asrar Ghani4, David M Martin5, Hui Hu6, Mark S Gold7. 1. Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, FL, USA; Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, FL, USA. Electronic address: lbcottler@ufl.edu. 2. College of Medicine, University of Central Florida, Orlando, FL, USA. 3. Departments of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL, USA. 4. Spectre Group International, Wazir Akbar Khan, District 10, Kabul, Afghanistan. 5. JMJ Technologies, Lansdale, PA, USA. 6. Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, FL, USA. 7. Department of Psychiatry, McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL, USA.
Abstract
BACKGROUND: Previous attempts to assess the prevalence of drug use in Afghanistan have focused on subgroups that are not generalisable. In the Afghanistan National Urban Drug Use Study, we assessed risk factors and drug use in Afghanistan through self-report questionnaires that we validated with laboratory test confirmation using analysis of hair, urine, and saliva. METHODS: The study took place between July 13, 2010, to April 25, 2012, in 11 Afghan provinces. 2187 randomly selected households completed a survey, representing 19 025 household members. We completed surveys with the female head of the household about past and current drug use among members of their household. We also obtained hair, urine, and saliva samples from 5236 people in these households and tested them for metabolites of 13 drugs. FINDINGS: Of 2170 households with biological samples tested, 247 (11·4%) tested positive for any drug. Overall, opioids were the most prevalent drug in the biological samples (5·6%), although prescription drugs (prescription pain pills, sedatives, and tranquilliser) were the most commonly reported in the past 30 days in the questionnaires (7·6%). Of individuals testing positive for at least one substance, opioids accounted for more than 50% of substance use in women and children, but only a third of substances in men, who predominantly tested positive for cannabinoids. After controlling for age with direct standardisation, individual prevalence of substance use (from laboratory tests) was 7·2% (95% CI 6·1-8·3) in men and 3·1% (2·5-3·7) in women-with a national prevalence of 5·1% (4·4-5·8) and a prevalence of 5·0% (4·1-5·8) in Kabul. Concordance between laboratory test results and self-reports was high. INTERPRETATION: These data suggest the female head of household to be a knowledgeable informant for household substance use. They also might provide insight into new avenues for targeted behavioural interventions and prevention messages.
BACKGROUND: Previous attempts to assess the prevalence of drug use in Afghanistan have focused on subgroups that are not generalisable. In the Afghanistan National Urban Drug Use Study, we assessed risk factors and drug use in Afghanistan through self-report questionnaires that we validated with laboratory test confirmation using analysis of hair, urine, and saliva. METHODS: The study took place between July 13, 2010, to April 25, 2012, in 11 Afghan provinces. 2187 randomly selected households completed a survey, representing 19 025 household members. We completed surveys with the female head of the household about past and current drug use among members of their household. We also obtained hair, urine, and saliva samples from 5236 people in these households and tested them for metabolites of 13 drugs. FINDINGS: Of 2170 households with biological samples tested, 247 (11·4%) tested positive for any drug. Overall, opioids were the most prevalent drug in the biological samples (5·6%), although prescription drugs (prescription pain pills, sedatives, and tranquilliser) were the most commonly reported in the past 30 days in the questionnaires (7·6%). Of individuals testing positive for at least one substance, opioids accounted for more than 50% of substance use in women and children, but only a third of substances in men, who predominantly tested positive for cannabinoids. After controlling for age with direct standardisation, individual prevalence of substance use (from laboratory tests) was 7·2% (95% CI 6·1-8·3) in men and 3·1% (2·5-3·7) in women-with a national prevalence of 5·1% (4·4-5·8) and a prevalence of 5·0% (4·1-5·8) in Kabul. Concordance between laboratory test results and self-reports was high. INTERPRETATION: These data suggest the female head of household to be a knowledgeable informant for household substance use. They also might provide insight into new avenues for targeted behavioural interventions and prevention messages.
Authors: Louisa Degenhardt; Jason Grebely; Jack Stone; Matthew Hickman; Peter Vickerman; Brandon D L Marshall; Julie Bruneau; Frederick L Altice; Graeme Henderson; Afarin Rahimi-Movaghar; Sarah Larney Journal: Lancet Date: 2019-10-23 Impact factor: 79.321
Authors: Abdul Subor Momand; Elizabeth Mattfeld; Brian Morales; Manzoor Ul Haq; Thom Browne; Kevin E O'Grady; Hendrée E Jones Journal: Int J Pediatr Date: 2017-07-05
Authors: Vincent DeGennaro Jr; Stuart Malcolm; Lindsay Crompton; Krishna Vaddiparti; Lazarus K Mramba; Catherine Striley; Linda Cottler; Kellee Taylor; Robert Leverence Journal: BMJ Open Date: 2018-04-20 Impact factor: 2.692
Authors: Alyssa D Higgins; Richard J Dunn; Omer Malikzai; Mirwais Ahmadzai; Jerad M Gardner; Benjamin K Stoff; Josette R McMichael Journal: Dermatopathology (Basel) Date: 2022-07-15
Authors: Mohammad Shoaib Hamrah; Mohammad Hassan Hamrah; Mohammad Hussain Hamrah; Ahmad Edris Hamrah; Toba Dahi; Bagher Pahlavanzade; Abdurrahman Charkazi; Mohammad Hashem Hamrah Journal: Avicenna J Med Date: 2019-10-03